PATENT CLAIM ANALYSIS

Application Number: 16297316
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-06
Patent Classification: ["514", "04400A"]

Abstract:
This invention relates to compounds, compositions, and methods useful for reducing Glycolate Oxidase (HAO1) target RNA and protein levels via use of dsRNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.

Claim (Index 112):
The method of  claim 111 , wherein the subject has primary hyperoxaluria 1 (PH1).

Metadata:
- Claim Count in Document: 19.0
- Percentile: 99.0
- Lexical Diversity: 1.1875
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15616254', '14583200', '15793441', '16297354', '15102181']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.9078286336930516
- 35 USC 102 Novelty (BERT): 0.6921530106978633
- Combined Prediction Score: 0.8862610713935328
- Mean Citation Score: 891.0236259999997
- Max Citation Score: 948.5961
- Similarity Product: 688.0221925388037

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test